MoneyWorks4Me

Anuh Pharma - Quaterly Results

19 May 2023 Evaluate
The revenue zoomed 21.97% to Rs. 1573.10 millions for the quarter ended March 2023 as compared to Rs. 1289.70 millions during the corresponding quarter last year.A slim rise of 7.82% was recorded in the Net profit for the quarter ended March 2023 to Rs. 96.23  millions  From Rs. 89.25 millions.Operating Profit saw a handsome growth to 152.70 millions from 148.99 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1573.10 1289.70 21.97 5274.86 4866.46 8.39 5274.86 4866.46 8.39
Other Income 10.37 10.29 0.78 61.15 51.97 17.66 61.15 51.97 17.66
PBIDT 152.70 148.99 2.49 573.90 520.43 10.27 573.90 520.43 10.27
Interest 0.23 -1.77 -112.99 2.18 9.61 -77.32 2.18 9.61 -77.32
PBDT 152.47 150.76 1.13 571.72 510.82 11.92 571.72 510.82 11.92
Depreciation 24.07 30.07 -19.95 97.00 119.60 -18.90 97.00 119.60 -18.90
PBT 128.40 120.69 6.39 474.72 391.22 21.34 474.72 391.22 21.34
TAX 32.17 31.44 2.32 112.91 85.61 31.89 112.91 85.61 31.89
Deferred Tax -5.93 -4.56 30.04 -8.29 -9.95 -16.68 -8.29 -9.95 -16.68
PAT 96.23 89.25 7.82 361.81 305.61 18.39 361.81 305.61 18.39
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 9.71 11.55 -15.97 10.88 10.69 1.74 10.88 10.69 1.74
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..